Chiara Cazzaniga

Chiara Cazzaniga

Auto-generated profile, based on publicly available information

Chiara Cazzaniga

Centre for Chromosome Biology, School of Biological and Chemical Sciences, University of Galway 1 , Galway

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 June 2020 in EMBO Reports
Verified
Journal Article
Open access
PDF file
MRMichael D Rainey
Michael D Rainey
AQAisling Quinlan
Aisling Quinlan
CCChiara Cazzaniga
Chiara Cazzaniga
SMSofija Mijic
Sofija Mijic
OMOliviano Martella
Oliviano Martella
CSCorrado Santocanale
Corrado Santocanale
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.

29 March 2024 in Science Advances
Verified
Journal Article
Open access
SRSyed Arif Abdul Rehman
Syed Arif Abdul Rehman
CCChiara Cazzaniga
Chiara Cazzaniga
ENElena Di Nisio
Elena Di Nisio
OAOdetta Antico
Odetta Antico
AKAxel Knebel
Axel Knebel
VCVirginia De Cesare
Virginia De Cesare
E2-conjugating enzymes (E2s) play a central role in the enzymatic cascade that leads to the attachment of ubiquitin to a substrate. This process, termed ubiquitylation, is required to maintain cellular homeostasis and affects almost all cellular process. By interacting with multiple E3 ligases, E2s dictate the ubiquitylation landscape within the cell. Since its discovery, ubiquitylation has been regarded as a posttranslational modification that specifically targets lysine side chains (canonical ubiquitylation). We used Matrix-Assisted Laser Desorption/Ionization-Time Of Flight Mass Spectrometry to identify and characterize a family of E2s that are instead able to conjugate ubiquitin to serine and/or threonine. We used structural modeling and prediction tools to identify the key activity determinants that these E2s use to interact with ubiquitin as well as their substrates. Our results unveil the missing E2s necessary for noncanonical ubiquitylation, underscoring the adaptability and versatility of ubiquitin modifications.

12 June 2024 in Journal of Cell Biology
Verified
Journal Article
Open access
PDF file
AGAnja Göder
Anja Göder
CMChrystelle Maric
Chrystelle Maric
MRMichael D. Rainey
Michael D. Rainey
AOAisling O’cOnnor
Aisling O’cOnnor
CCChiara Cazzaniga
Chiara Cazzaniga
CSCorrado Santocanale
Corrado Santocanale
CDC7 kinase is crucial for DNA replication initiation and is involved in fork processing and replication stress response. Human CDC7 requires the binding of either DBF4 or DRF1 for its activity. However, it is unclear whether the two regulatory subunits target CDC7 to a specific set of substrates, thus having different biological functions, or if they act redundantly. Using genome editing technology, we generated isogenic cell lines deficient in either DBF4 or DRF1: these cells are viable but present signs of genomic instability, indicating that both can independently support CDC7 for bulk DNA replication. Nonetheless, DBF4-deficient cells show altered replication efficiency, partial deficiency in MCM helicase phosphorylation, and alterations in the replication timing of discrete genomic regions. Notably, we find that CDC7 function at replication forks is entirely dependent on DBF4 and not on DRF1. Thus, DBF4 is the primary regulator of CDC7 activity, mediating most of its functions in unperturbed DNA replication and upon replication interference.